Analyst Price Targets — PEPG
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 18, 2026 12:25 pm | Debjit Chattopadhyay | Guggenheim | $7.00 | $6.79 | TheFly | PepGen price target raised to $7 from $6 at Guggenheim |
| October 28, 2025 11:16 am | Andrew Fein | H.C. Wainwright | $18.00 | $5.28 | TheFly | PepGen price target raised to $18 from $12 at H.C. Wainwright |
| September 25, 2025 5:06 pm | — | Stifel Nicolaus | $12.00 | $5.88 | TheFly | PepGen price target raised to $12 from $9 at Stifel |
| September 25, 2025 12:03 pm | — | Wedbush | $9.00 | $5.88 | TheFly | PepGen price target raised to $9 from $7 at Wedbush |
| December 21, 2022 6:26 am | — | H.C. Wainwright | $26.00 | $14.51 | Benzinga | HC Wainwright & Co. Initiates Coverage On PepGen with Buy Rating, Announces Price Target of $26 |
| November 10, 2022 1:35 pm | — | Leerink Partners | $33.00 | $12.50 | Benzinga | SVB Leerink Maintains Outperform on PepGen, Lowers Price Target to $33 |
Latest News for PEPG
NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, April 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PepGen Inc. ("PepGen" or the "Company") (NASDAQ: PEPG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PEPG.
U.S. House Trading
No House trades found for PEPG.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.